Opportunity Information: Apply for PAR 20 164

The National Institutes of Health (NIH) funding opportunity titled "Mechanisms and Consequences of Sleep Disparities in the U.S. (R01 - Clinical Trial Not Allowed)" (Funding Opportunity Number PAR-20-164) supports investigator-initiated research projects that explain why sleep deficiencies are more common or more severe in U.S. health disparity populations and how those sleep deficiencies contribute to unequal health outcomes. The central goal is to move beyond simply documenting that sleep problems differ across groups and instead clarify the underlying mechanisms driving those differences, along with the downstream effects on health. This FOA uses the NIH R01 mechanism, which is the standard multi-year research project grant intended for well-developed, hypothesis-driven studies.

The scientific focus is on sleep deficiencies and sleep health as both outcomes and contributors to broader disparities. Projects are expected to address mechanistic pathways that may include biological, behavioral, social, and environmental contributors to poor sleep in populations experiencing health disparities. The opportunity also emphasizes consequences: how insufficient sleep duration, poor sleep quality, circadian disruption, sleep disorders, or other dimensions of sleep deficiency may influence disparities in cardiometabolic health, mental health, cognitive outcomes, immune function, pain, maternal and child health, and other health endpoints. In practice, competitive applications would likely connect sleep-related exposures and contexts (for example, shift work, neighborhood factors, chronic stress, discrimination, housing conditions, noise, light exposure, or occupational demands) to measurable sleep outcomes, and then link those sleep outcomes to subsequent health trajectories that differ across populations.

This FOA is explicitly labeled "Clinical Trial Not Allowed," meaning applicants should not propose NIH-defined clinical trials that prospectively assign human participants to an intervention to evaluate effects on health-related outcomes. Observational, epidemiological, and mechanistic human studies are generally consistent with this restriction, as are many types of secondary data analyses, cohort studies, laboratory-based human physiology work that does not meet the NIH clinical trial definition, and animal or translational studies as appropriate to the research question. Applicants need to design their approach so it advances understanding of mechanisms and consequences without crossing into a disallowed clinical trial framework.

Eligibility is broad and reflects NIH's intent to support a wide range of institutions and community-engaged research capacity. Eligible applicants include state, county, and city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations other than federally recognized tribal governments; public housing authorities and Indian housing authorities; nonprofits with or without 501(c)(3) status (excluding institutions of higher education in those nonprofit categories); for-profit organizations other than small businesses; and small businesses. The announcement also highlights additional eligible applicant types such as Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISIs); Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs); faith-based or community-based organizations; eligible federal agencies; regional organizations; and U.S. territories or possessions. These categories underscore a strong openness to proposals that are embedded in, or directly partnered with, communities affected by sleep and health inequities.

The FOA includes important rules for non-U.S. participation. Non-domestic (non-U.S.) entities, including foreign institutions, are not eligible to apply as the primary applicant organization, and non-domestic components of U.S. organizations are also not eligible to apply. At the same time, foreign components are allowed as defined in the NIH Grants Policy Statement, which typically means a U.S.-based applicant can include a foreign collaboration component when it is well-justified and adds unique expertise, resources, populations, or scientific value that cannot be readily obtained in the United States.

Administratively, this is a discretionary grant program run by NIH within the U.S. Department of Health and Human Services, and the funding activity category is listed under education and health. The FOA references multiple CFDA numbers (now commonly tracked under Assistance Listings), indicating participation across several NIH Institutes and Centers with relevant missions. The record indicates the original closing date was 2022-07-14, and no award ceiling or expected number of awards is specified in the provided source text, which is common for many NIH FOAs where budgets depend on project scope and institute-specific considerations.

Overall, this opportunity is aimed at producing actionable scientific insight into why sleep disparities exist and how they matter for health, with the long-term expectation that stronger mechanistic understanding will inform more precise public health strategies, clinical awareness, and policy approaches that reduce inequities. Competitive projects would typically bring together rigorous sleep measurement, careful attention to disparity-relevant contexts, and clear analytic plans that can disentangle pathways linking social and environmental conditions to sleep and, in turn, to unequal health outcomes across U.S. populations.

  • The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Mechanisms and Consequences of Sleep Disparities in the U.S. (R01 - Clinical Trial Not Allowed)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.233, 93.273, 93.307, 93.393, 93.394, 93.395, 93.396, 93.399, 93.837, 93.838, 93.839, 93.840, 93.853, 93.866.
  • This funding opportunity was created on 2020-04-03.
  • Applicants must submit their applications by 2022-07-14. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for PAR 20 164

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Frequently Asked Questions (FAQs)

What is the title and funding opportunity number for this grant?

The funding opportunity is titled "Mechanisms and Consequences of Sleep Disparities in the U.S. (R01 - Clinical Trial Not Allowed)" and the Funding Opportunity Number is PAR-20-164.

Which agency is offering this opportunity?

This is a discretionary grant program offered by the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS).

What is the main purpose of this funding opportunity?

The purpose is to support investigator-initiated research that explains (1) why sleep deficiencies are more common or more severe in U.S. health disparity populations, and (2) how those sleep deficiencies contribute to unequal health outcomes. The focus is on moving beyond documenting differences to clarifying mechanisms and downstream health effects.

What grant mechanism does this FOA use?

This FOA uses the NIH R01 mechanism, which is the standard multi-year research project grant intended for well-developed, hypothesis-driven studies.

What kinds of research topics are encouraged?

Projects are expected to address both mechanisms and consequences of sleep disparities. Mechanistic pathways may include biological, behavioral, social, and environmental contributors to poor sleep in populations experiencing health disparities. The FOA also emphasizes studying how sleep deficiencies contribute to broader health disparities.

What sleep-related outcomes or exposures are in scope?

The FOA highlights sleep deficiencies and sleep health as outcomes and as contributors to disparities, including insufficient sleep duration, poor sleep quality, circadian disruption, sleep disorders, and other dimensions of sleep deficiency. Example contextual exposures include shift work, neighborhood factors, chronic stress, discrimination, housing conditions, noise, light exposure, and occupational demands.

What health outcomes can be linked to sleep disparities under this opportunity?

The FOA points to consequences of sleep deficiency that may influence disparities in cardiometabolic health, mental health, cognitive outcomes, immune function, pain, maternal and child health, and other health endpoints.

Does this FOA allow clinical trials?

No. The FOA is explicitly labeled "Clinical Trial Not Allowed," meaning applicants should not propose NIH-defined clinical trials that prospectively assign human participants to an intervention to evaluate effects on health-related outcomes.

What types of studies are generally consistent with the "Clinical Trial Not Allowed" restriction?

The description indicates that observational, epidemiological, and mechanistic human studies are generally consistent with the restriction. It also notes that many types of secondary data analyses, cohort studies, laboratory-based human physiology work that does not meet the NIH clinical trial definition, and animal or translational studies may be appropriate depending on the research question.

How should applicants handle study design given the clinical trial restriction?

Applicants are expected to design approaches that advance understanding of mechanisms and consequences of sleep disparities without crossing into a disallowed clinical trial framework (i.e., without prospectively assigning participants to an intervention to evaluate health-related outcomes).

Who is eligible to apply?

Eligibility is broad. Eligible applicants include state, county, and city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations other than federally recognized tribal governments; public housing authorities and Indian housing authorities; nonprofits with or without 501(c)(3) status (excluding institutions of higher education in those nonprofit categories); for-profit organizations other than small businesses; and small businesses.

Are community-based and faith-based organizations eligible?

Yes. The FOA highlights faith-based or community-based organizations among additional eligible applicant types.

Are minority-serving institutions specifically included as eligible applicants?

Yes. The FOA highlights additional eligible applicant types such as Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISIs); Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); and Tribally Controlled Colleges and Universities (TCCUs).

Are U.S. territories or possessions eligible?

Yes. U.S. territories or possessions are listed among the additional eligible applicant types.

Can federal agencies apply?

Yes. Eligible federal agencies are included among the additional eligible applicant types listed in the FOA summary.

Can non-U.S. (foreign) organizations apply as the primary applicant?

No. Non-domestic (non-U.S.) entities, including foreign institutions, are not eligible to apply as the primary applicant organization.

Can a U.S. organization include a non-U.S. component?

Non-domestic components of U.S. organizations are stated as not eligible to apply. However, foreign components are allowed as defined in the NIH Grants Policy Statement when well-justified and when they add unique expertise, resources, populations, or scientific value that cannot be readily obtained in the United States.

What is meant by a "foreign component" being allowed?

As described, a U.S.-based applicant may include a foreign collaboration component if it is justified and provides unique expertise, resources, populations, or scientific value that cannot be readily obtained in the U.S., consistent with the NIH Grants Policy Statement definition of a foreign component.

What is the funding activity category for this opportunity?

The funding activity category is listed under education and health.

Do multiple NIH Institutes or Centers participate in this FOA?

Yes. The FOA references multiple CFDA numbers (now commonly tracked under Assistance Listings), indicating participation across several NIH Institutes and Centers with relevant missions.

Is there an award ceiling or a stated expected number of awards?

No award ceiling or expected number of awards is specified in the provided source text. This is common for many NIH FOAs where budgets depend on project scope and institute-specific considerations.

What was the closing date listed for this FOA?

The record indicates the original closing date was 2022-07-14.

What types of applications are likely to be competitive based on the description?

Based on the description, competitive applications would typically connect sleep-related exposures and contexts (such as shift work, neighborhood factors, stress, discrimination, housing, noise, and light) to measurable sleep outcomes, and then link those sleep outcomes to subsequent health trajectories that differ across populations. Strong proposals would combine rigorous sleep measurement, careful attention to disparity-relevant contexts, and clear analytic plans to disentangle pathways from social and environmental conditions to sleep and then to unequal health outcomes.

What is the long-term goal or intended impact of this research?

The long-term expectation is that stronger mechanistic understanding of sleep disparities will inform more precise public health strategies, clinical awareness, and policy approaches aimed at reducing inequities.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education, Health

Next opportunity: Advancing Research to Develop Improved Measures and Methods for Understanding Multimorbidity (R01 Clinical Trial Optional)

Previous opportunity: Novel Synthetic Nucleic Acid Technology Development (R01 Clinical Trial not allowed)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 20 164

 

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 20 164) also looked into and applied for these:

Funding Opportunity
Addressing Racial Disparities in Maternal Mortality and Morbidity (R01 Clinical Trial Optional) Apply for RFA MD 20 008

Funding Number: RFA MD 20 008
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Reducing Stigma Related to Drug Use in Human Service Settings (R34 Clinical Trial Required) Apply for RFA DA 21 001

Funding Number: RFA DA 21 001
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $225,000
Reducing Stigma Related to Drug Use in Human Service Settings (R21 Clinical Trial Optional) Apply for RFA DA 21 002

Funding Number: RFA DA 21 002
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
New Informatics Tools and Methods to Enhance U.S. Cancer Surveillance Research (U01 Clinical Trial Optional) Apply for PAR 20 170

Funding Number: PAR 20 170
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01- Clinical Trial Optional) Apply for PA 20 172

Funding Number: PA 20 172
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Identifying Innovative Mechanisms or Interventions that Target Multimorbidity and Its Consequences (R01 Clinical Trial Optional) Apply for PAR 20 180

Funding Number: PAR 20 180
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Advancing Research to Develop Improved Measures and Methods for Understanding Multimorbidity (R01 Clinical Trial Optional) Apply for PAR 20 179

Funding Number: PAR 20 179
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Research Project Grant (Parent R01 Clinical Trial Required) Apply for PA 20 183

Funding Number: PA 20 183
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Large scale mapping and/or molecular profiling of ensembles and/or cell-types mediating opioid action in the rodent brain (R01 - Clinical Trial Not Allowed) Apply for PAR 20 182

Funding Number: PAR 20 182
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $1,000,000
Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed) Apply for PA 20 190

Funding Number: PA 20 190
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Substance Use/Substance Use Disorder Dissertation Research Award (R36 - Clinical Trials Optional) Apply for PA 20 208

Funding Number: PA 20 208
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Single Cell Opioid Responses in the Context of HIV (SCORCH) Program Expansion: CNS Data Generation for Chronic Opioid, Methamphetamine, and/or Cocaine Exposures (U01 Clinical Trial Not Allowed) Apply for RFA DA 21 019

Funding Number: RFA DA 21 019
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
HIV Infection of the Central Nervous System (R01 Clinical Trial Not Allowed) Apply for PA 20 149

Funding Number: PA 20 149
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Eradication of HIV-1 from Central Nervous system Reservoirs (R01 Clinical Trial Not Allowed) Apply for PA 20 151

Funding Number: PA 20 151
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
NIDA Avant-Garde Award Program for HIV/AIDS and Substance Use Disorder Research (DP1, Clinical Trial Optional) Apply for PAR 20 221

Funding Number: PAR 20 221
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $700,000
Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1 Clinical Trial Optional) Apply for PAR 20 225

Funding Number: PAR 20 225
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $300,000
Avenir Award Program for Research on Substance Use Disorders and HIV/AIDS (DP2 Clinical Trial Optional) Apply for PAR 20 224

Funding Number: PAR 20 224
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Advancing HIV/AIDS Research through Computational Neuroscience FOA (R01 - Clinical Trial Optional) Apply for RFA DA 21 013

Funding Number: RFA DA 21 013
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Emergency Awards: Research Projects in SARS-CoV-2 Serological Sciences (U01 Clinical Trial Optional) Apply for RFA CA 20 039

Funding Number: RFA CA 20 039
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Emergency Awards: SARS-CoV-2 Serological Sciences Centers of Excellence (U54 Clinical Trial Optional) Apply for RFA CA 20 038

Funding Number: RFA CA 20 038
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 20 164", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: